🔎 Trials Near Me

Akèy › Obèsite › Pennsylvania › Pittsburgh

Etid klinik pou Obèsite nan Pittsburgh, PA

13 etid pou Obèsite ap chèche patisipan nan sit nan ak bò kote Pittsburgh (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight

Ap rekriteFaz 3
  • Heritage Valley Medical Group, Beaver · 24 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07564414

A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight

Ap rekriteFaz 3
  • UPMC Child Hosp-Pittsburgh, Pittsburgh
Laj 8 a 18 · Tout sèks · Mizajou Sep 30, 2026 · NCT07253285

A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)

Ap rekriteFaz 3
  • UPMC Children's Hospital of Pittsburgh, Pittsburgh
Laj 6 a 17 · Tout sèks · Mizajou Sep 24, 2026 · NCT06672549

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes

Ap rekriteFaz 3
  • Preferred Primary Care Physicians, Preferred Clinical Research-St. Clair, Pittsburgh
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07282600

A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin

Ap rekriteFaz 3
  • Preferred Primary Care Physicians, Preferred Clinical Research (Ofc 18), Pittsburgh
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07392190

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

Ap rekriteFaz 3
  • Heritage Valley Multispecialty Group Inc, Beaver · 24 mi lwen
Laj 45 a 99 · Tout sèks · Mizajou Sep 22, 2026 · NCT07037433

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

Ap rekriteFaz 3
  • AURORA-2 Clinical Site, Pittsburgh
Laj 18 ak plis · Tout sèks · Mizajou Sep 16, 2026 · NCT07743450

Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity

Ap rekriteFaz 3
  • University of Pittsburgh Medical Center, Pittsburgh
Laj 18 a 99 · Tout sèks · Mizajou Sep 16, 2026 · NCT07037459

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes

Ap rekriteFaz 3
  • VA Pittsburgh Healthcare System, Pittsburgh
Laj 18 ak plis · Tout sèks · Mizajou Sep 14, 2026 · NCT07351058

Intensive Glycemic Targets in Overweight and Obese Women With Gestational Diabetes

Ap rekrite
  • University of Pittsburgh, Pittsburgh
Laj 18 a 45 · Fanm · Mizajou Jun 24, 2026 · NCT05124808

The Effects of Strength Training on Muscle Mass and Mental Health in Adults Taking Obesity Medication

Ap rekrite
  • Physical Activity Research Center, University of Pittsburgh, Pittsburgh
Laj 18 ak plis · Tout sèks · Mizajou Jun 24, 2026 · NCT07652333

Brain Health in Youth With Normal Weight, Overweight and Obesity at Risk for Type 2 Diabetes (T2D)

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
  • UPMC Children's Hospital of Pittsburgh, Pittsburgh
Laj 12 a 17 · Tout sèks · Mizajou Dec 18, 2025 · NCT05277558

Etid Obèsite nan lòt vil

Lòt etid nan Pittsburgh

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.